Clinical studies recruiting near Nampa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · Alliance for Clinical Trials in Oncology · NCT07321652 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Saint Alphonsus Cancer Care Center-Nampa · Alliance for Clinical Trials in Oncology · NCT07091617 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Saint Alphonsus Cancer Care Center-Nampa · SWOG Cancer Research Network · NCT06769126 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Saint Luke's Cancer Institute - Nampa · Alliance for Clinical Trials in Oncology · NCT06931340 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · Canadian Cancer Trials Group · NCT06592924 A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin
Phase 3 · Saint Alphonsus Medical Center · Pfizer · NCT06866405 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Saint Luke's Cancer Institute - Nampa · SWOG Cancer Research Network · NCT05806515 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Saint Alphonsus Cancer Care Center-Nampa · Alliance for Clinical Trials in Oncology · NCT04242095 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT05256225 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT05554393 Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · Saint Luke's Cancer Institute - Nampa · SWOG Cancer Research Network · NCT05633615 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT06498635 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Saint Alphonsus Cancer Care Center-Nampa · NRG Oncology · NCT05327686 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Saint Alphonsus Nampa Cancer Care Center · Pfizer · NCT07222800 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · NRG Oncology · NCT04852887 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · Alliance for Clinical Trials in Oncology · NCT05677490 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT06058377 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Saint Luke's Cancer Institute - Nampa · SWOG Cancer Research Network · NCT04511013 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Saint Alphonsus Cancer Care Center-Nampa · NRG Oncology · NCT05080673 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Saint Alphonsus Cancer Care Center-Nampa · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT05987241 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT05564377 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Saint Alphonsus Cancer Care Center-Nampa · SWOG Cancer Research Network · NCT04205968 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · Saint Alphonsus Cancer Care Center-Nampa · National Cancer Institute (NCI) · NCT06317649

Look up another city

Look up another condition